Welcome to our dedicated page for MAXIMUS news (Ticker: MMS), a resource for investors and traders seeking the latest updates and insights on MAXIMUS stock.
Maximus, Inc. (MMS) has been a leader in providing business process and technology solutions since 1975, with a mission of 'helping government serve the people.' Employing over 16,000 professionals, Maximus operates across North America, Australia, the United Kingdom, and Saudi Arabia, delivering high-quality services to government agencies.
The company is renowned for its expertise in managing government health and human services programs. It plays a pivotal role in enhancing the efficiency, cost-effectiveness, and quality of government-sponsored benefit programs, including Medicaid, Medicare, Health Insurance BC, and child support programs. A substantial portion of Maximus' revenue is derived from long-term contractual agreements with global governments, with the U.S. Federal Services segment being the largest contributor.
In recent achievements, Maximus has demonstrated its commitment to social responsibility through various community service projects. For instance, during GivingTuesday, Maximus employees volunteered their time and resources to support the Catherine McAuley Center, helping women and children transition from homelessness to independent living. This initiative is part of a broader effort led by the Maximus Foundation, an independent nonprofit organization established by the Maximus Board of Directors in 2000.
The Maximus Foundation focuses on grantmaking and corporate-wide humanitarian efforts, empowering employees to make a difference in their communities. Employee donors pool their charitable contributions through the Foundation, which doubles their impact via Maximus' dollar-for-dollar matching pledge. This commitment to social good is evident in the support provided to initiatives like the Atlanta Mission, which addresses homelessness by offering comprehensive services to individuals and families in need.
With a forward-looking approach, Maximus continues to innovate and expand its impact. The Foundation's 2023 Annual Report highlights a year of significant achievements and looks ahead to new grantmaking strategies for 2025, aiming for a more equitable and inclusive future. Through its dedicated efforts, Maximus not only serves government clients but also plays a crucial role in improving the overall wellbeing of communities worldwide.
Stay updated with the latest developments, projects, and news from Maximus by visiting their official website and following their social media channels.
Maximus (NYSE: MMS) is scheduled to release its financial results for the three and six months ended March 31, 2023, after market close on May 3, 2023. A conference call will follow on May 4, 2023, at 9:00 a.m. ET, allowing shareholders to submit questions by email until one hour prior. The call is accessible via webcast or by phone. For those unable to attend live, a recording will be available on Maximus's investor site.
Maximus (MMS) reported Q1 FY2023 financial results, with revenue increasing 8.5% to $1.25 billion and organic growth at 10.3%. Diluted EPS was $0.65, with adjusted EPS at $0.94. Due to the scheduled restart of Medicaid redeterminations, the company raised its FY23 revenue guidance to $4.85-$5.0 billion and adjusted EPS guidance to $4.00-$4.30. U.S. Services revenue rose 13.7% to $439.5 million, while the operating margin decreased to 8.6%. The cash dividend of $0.28 per share will be paid on February 28, 2023. Maximus remains focused on capturing growth in government services amid a recovery from pandemic-related challenges.
Maximus (NYSE: MMS) has declared a quarterly cash dividend of $0.28 per share, scheduled for payment on February 28, 2023. Shareholders of record on February 15, 2023 will receive this dividend. As a prominent provider of government services globally, Maximus aims to enhance public service delivery through innovative business process management and technology solutions.
Maximus (NYSE: MMS) will release its financial results for the three months ended December 31, 2022, after market close on February 8, 2023. A conference call will follow on February 9, 2023, at 9:00 a.m. ET, where shareholders can submit questions via email. The call will be accessible to the public through a webcast and by phone. Maximus is a global leader in government services, focusing on improving public service delivery through innovative solutions and operational excellence.
Maximus (NYSE: MMS) has secured a $100 million contract with the Centers for Disease Control and Prevention (CDC) for one base year plus four option years. The contract aims to enhance the CDC-INFO program, providing vital health information to Americans. Maximus will utilize its technology and operational expertise to improve service delivery, especially post-COVID-19. The company has previously supported the CDC-VAX program during the pandemic, earning multiple awards for its efforts.
Maximus (NYSE: MMS) announced it will release its financial results for the fiscal year and quarter ending September 30, 2022, after market close on November 21, 2022. A conference call will follow on November 22, 2022, at 9:00 a.m. ET. Shareholders can submit questions for management via email until one hour prior to the call. The event will be accessible to the public through a webcast and by phone.
Maximus (NYSE:MMS) has announced the transition of Dr. Arvenita W. Cherry to the role of President of the Maximus Foundation, effective October 1. She succeeds Dr. John Boyer, who served for 17 years and will remain as Chairman until his retirement later this fiscal year. The Maximus Foundation is dedicated to supporting community and healthcare initiatives, recently distributing $2 million in grants to 167 nonprofits in the U.S. Dr. Cherry aims to align the foundation’s focus with the company’s diversity, equity, and inclusion strategies.
Maximus (NYSE: MMS) has declared a quarterly cash dividend of $0.28 per share, set to be paid on November 30, 2022. Shareholders must be on record by November 15, 2022 to qualify for this dividend. This move highlights Maximus's commitment to returning income to its shareholders, reflecting the company's financial health and operational stability.
Maximus (NYSE: MMS) has secured a new contract valued at
Maximus (NYSE: MMS) reported a revenue decline of $118 million for Q3 FY2022, totaling $1.13 billion, impacted by a $413 million reduction in COVID-19 response work. Despite this, organic growth in the U.S. Federal Services Segment and a pipeline of signed contracts totaling $4.02 billion highlight future growth potential. Diluted EPS stood at $0.51, affected by an $11.7 million write-down. Full-year guidance remains unchanged for revenue at $4.6 billion, while EPS is projected between $2.85 and $3.05. A quarterly dividend of $0.28 per share will be paid on August 31, 2022.
FAQ
What is the current stock price of MAXIMUS (MMS)?
What is the market cap of MAXIMUS (MMS)?
What services does Maximus, Inc. provide?
In which countries does Maximus operate?
What is the mission of Maximus, Inc.?
What is the Maximus Foundation?
How does Maximus support the community?
What are some recent projects by Maximus?
How does Maximus generate most of its revenue?
How many employees does Maximus have?
What recent achievements has Maximus made?
Where can I find more information about Maximus' initiatives?
